Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of the Apollo System for Children With ADHD

NCT: NCT05308706 · ACTIVE_NOT_RECRUITING

NCT IDNCT05308706
StatusACTIVE_NOT_RECRUITING
Start Date2022-03-18
Completion2027-08-15

Brief Summary

To determine the extent to which the Apollo System is effective in reducing symptomatology associated with ADHD.

Frequently Asked Questions

What is Efficacy of the Apollo System for Children With ADHD?

Efficacy of the Apollo System for Children With ADHD is a clinical trial registered under NCT05308706. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05308706?

The current status of NCT05308706 (Efficacy of the Apollo System for Children With ADHD) is: ACTIVE_NOT_RECRUITING.

When did Efficacy of the Apollo System for Children With ADHD start?

Efficacy of the Apollo System for Children With ADHD started on 2022-03-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑